AUTOLOGOUS PLATELET‐RICH PLASMA: A REVIEW OF SCIENTIFIC ARTICLES ON THE STUDY OF EFFICIENCY IN TREATMENT OF ANDROGENETIC ALOPECIA IN MEN AND WOMEN
This article is an analysis of scientific publications that reflect the experience of using autologous plateletrich plasma in patients with androgenic alopecia (AGA), a multifactorial genetically predisposed disease caused by the influence of exogenous or endogenous triggers responsible for the clinical manifestations of pathology. Attention to this topic is due to the significant prevalence of AGA, as well as unsatisfactory results in achieving a positive therapeutic effect.
Positive results were obtained during the 12 clinical studies among the conducted ones, no positive dynamics were observed in the end of other 2 studies. It can be noted that different methods and parameters of centrifugation were used to perform these experiments: PRP used differ or PRP activators were not used at all, variations were observed in methods for evaluating the obtained results, the multiplicity of procedures and intervals between them, the procedure technique (using a mezoroller, anesthetics, injections, etc.). Studies with a negative result were characterized by the smallest number of procedures performed (1 or 2 procedures), and methods for evaluating the results cannot be called sufficiently reliable (a magnifying glass). It is obvious that the use of PRP has a positive effect on the state of AGA and can be used with approved methods of this disease treatment. However, the published results of only a small number of clinical trials on the effectiveness of PRP for hair growth cannot be considered objective. In addition, there is no published agreed protocol for the standard use of PRP, and the use of growth factors and stimulants in the expression of their genes still requires comparative evaluation with preparations approved for the treatment of hair. Thus, the method of PRP using can be considered as a method of treating AGA, however, it is necessary to continue research for further study and standardization of this technique.
Trihologija. Vtoroe izdanie, dopolnennoe i pererabotannoe / A. Zlotogorskij, D. Shapiro [i dr.]; pod red. A. Litusa; per. s angl. Ju. Ovcharenko. – K.: Izdatel'stvo, 2016. – 276 p., il.
Ovcharenko Ju.S., Kachuk Ju.V. Androgeneticheskaja alopecija. // Les Nouvelles Esthetiques Ukraina. – 2015. − No. 3 (91). − P. 70–78.
Botchkarev V. A., Kishimoto J. Molecular control of epithelial–mesenchymal interactions during hair follicle cycling // Journal of Investigative Dermatology Symposium Proceedings. – Elsevier, 2003. – Т. 8. – No. 1. – P. 46–55.
Alexandrescu D. T., Kauffman C. L., Dasanu C. A. The cutaneous epidermal growth factor network: Can it be translated clinically to stimulate hair growth? // Dermatology online journal. – 2009. – Т. 15. – No. 3.
Commo S., Gaillard O., Bernard B. A. The human hair follicle contains two distinct K19 positive compartments in the outer root sheath: a unifying hypothesis for stem cell reservoir? //Differentiation. – 2000. – Т. 66. – No. 4–5. – P. 157–164.
Cotsarelis G., Sun T. T., Lavker R. M. Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis // Cell. – 1990. – Т. 61. – No. 7. – P. 1329–1337.
Barrera A. The Role of Platelet Plasma Growth Factors in Male Pattern Baldness Surgery. – 2006.
Greco J., Brandt R. The effects of autologous platelet rich plasma and various growth factors on nontransplanted miniaturized hair //Hair Transplant Forum Int. – 2009. – Т. 19. – P. 49-50. 9. Betsi E. E. et al. Platelet-rich plasma injection is effective and safe for the treatment of alopecia // European Journal of Plastic Surgery. – 2013. – Т. 36. – No. 7. – P. 407–412.
Anitua E. et al. The effect of plasma rich in growth factors on pattern hair loss: a pilot study //Dermatologic Surgery. – 2017. – Т. 43. – No. 5. – P. 658–670.
ALvES R., Grimalt R. Randomized placebo-controlled, double-blind, half-head study to assess the efficacy of platelet-rich plasma on the treatment of androgenetic alopecia //Dermatologic Surgery. – 2016. – Т. 42. – No. 4. – P. 491-497.
Gentile P. et al. The effect of platelet‐rich plasma in hair regrowth: a randomized placebo-controlled trial // Stem cells translational medicine. – 2015. – Т. 4. – No. 11. – P. 1317–1323.
Cervelli V. et al. The effect of autologous activated platelet rich plasma (AA-PRP) injection on pattern hair loss: clinical and histomorphometric evaluation // BioMed research international. – 2014. – Т. 2014.
Singhal P. et al. Efficacy of platelet-rich plasma in treatment of androgenic alopecia // Asian journal of transfusion science. – 2015. – Т. 9. – No. 2. – P. 159.
Gupta S. et al. A study of the efficacy of platelet-rich plasma in the treatment of androgenetic alopecia in males // Indian Journal of Dermatology, Venereology, and Leprology. – 2017. – Т. 83. – No. 3. – P. 412.
Schiavone G. et al. Platelet-rich plasma for androgenetic alopecia: a pilot study // Dermatologic Surgery. – 2014. – Т. 40. – No. 9. – P. 1010–1019.
Gkini M. A. et al. Study of platelet-rich plasma injections in the treatment of androgenetic alopecia through an one-year period // Journal of cutaneous and aesthetic surgery. – 2014. – Т. 7. – No. 4. – P. 213.
Khatu S. S. et al. Platelet-rich plasma in androgenic alopecia: myth or an effective tool // Journal of cutaneous and aesthetic surgery. – 2014. – Т. 7. – No. 2. – P. 107.
Takikawa M. et al. Enhanced effect of platelet-rich plasma containing a new carrier on hair growth // Dermatologic Surgery. – 2011. – Т. 37. – No. 12. – P. 1721–1729.
Puig C. J., Reese R., Peters M. Double-blind, placebo-controlled pilot study on the use of platelet-rich plasma in women with female androgenetic alopecia // Dermatologic Surgery. – 2016. – Т. 42. – No. 11. – P. 1243–1247.
Mapar M. A., Shahriari S., Haghighizadeh M. H. Efficacy of platelet-rich plasma in the treatment of androgenetic (male-patterned) alopecia: A pilot randomized controlled trial // Journal of Cosmetic and Laser Therapy. – 2016. – Т. 18. – No. 8. – P. 452–455.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Journal of V. N. Karazin Kharkiv National University, series Medicine has following copyright terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work, with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.